Results 141 to 150 of about 6,976 (185)

Case Report: Perioperative application of trastuzumab deruxtecan in <i>HER2</i> exon 20 mutation-positive non-small cell lung cancer. [PDF]

Front Pharmacol
Li W, Xiao Z, Yang J, Liu L, Chai X, Zhang H.   +5 more
europepmc   +1 more source

Case Report: Trastuzumab deruxtecan plus toripalimab in ERBB2-amplified cervical mucosal melanoma. [PDF]

Front Oncol
Wang XX, Wang MX, Sui C.
europepmc   +1 more source

Early introduction of trastuzumab deruxtecan (T-DXd) in HER2 expressing rare gynecologic malignancies - How early is too early? [PDF]

Gynecol Oncol Rep
McEachron J, Bakkum-Gamez JN.
europepmc   +1 more source

Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report database. [PDF]

In Vivo
Kanbayashi Y, Morioka R, Takayama K, Hosohata K.   +3 more
europepmc   +1 more source

Trastuzumab deruxtecan: expanding the role of HER2-targeted therapy in solid tumors. [PDF]

Transl Cancer Res
Aboaid H, Myat YM, Jones DT, Thein KZ.
europepmc   +1 more source

Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort. [PDF]

Breast
Visani L, Ratosa I, Bartsch R, Linderholm B, Griguolo G, Saieva C, Becherini C, Valzano M, Salvestrini V, Starzer AM, Kus P, Bertini N, Rampini A, Mattioli C, Ribnikar D, Nori Cucchiari J, Orzalesi L, Bianchi S, Lambertini M, Guarneri V, Livi L, Meattini I.   +21 more
europepmc   +1 more source

ERRATUM: Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer

Joanna Kufel-Grabowska
openalex   +1 more source

Exceptional response to trastuzumab deruxtecan in recurrent neuroendocrine cervical cancer: A case report. [PDF]

Gynecol Oncol Rep
Tostrud L, Howitt BE, Mills M, Karam A, Bixel KL.   +4 more
europepmc   +1 more source

19P Body composition measures as a determinant of trastuzumab deruxtecan related toxicity and response

Shlomit Strulov Shachar, Rivka Kessner, Amir Sonnenblick, Yael Bar, Seth P. Lerner, A.T. Deutsch Lukatsky, Shlomi Peretz   +6 more
openalex   +1 more source

Trastuzumab Deruxtecan-Induced Myotoxicity: First Case Report About Myopathy in Patient With Normal Body Composition and Clinical Insights. [PDF]

Thorac Cancer
Qiao Z, Li L, Wang H, Dai S, Ye L.
europepmc   +1 more source